+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Probiotics, Prebiotics and Synbiotics. Technological Advancements Towards Safety and Industrial Applications. Edition No. 1

  • Book

  • 496 Pages
  • February 2022
  • John Wiley and Sons Ltd
  • ID: 5837732

In Probiotics, Prebiotics and Synbiotics: Technological Advancements Towards Safety and Industrial Applications, a team of distinguished researchers delivers an insightful exploration of various aspects of functional foods. The book includes information about critical facets of the production of these beneficial compounds, recent technological developments in the field, and their present and future commercial potential. The authors describe their mechanisms of action and their applications in several sectors.

Probiotics, Prebiotics and Synbiotics is divided into five parts. A general introduction about these substances begins the book and is followed by discussions of common probiotics, prebiotics, and synbiotics. Finally, a treatment of safety issues and regulatory claims, as well as their market potential, rounds out the resource.

Perfect for researchers, industry practitioners, and students working in or studying food processing and food microbiology, Probiotics, Prebiotics and Synbiotics is also an invaluable resource for professionals working in the field of food biotechnology.

Table of Contents

List of Contributors xvi

Preface xxi

1 Probiotics, Prebiotics and Synbiotics: Opportunities, Health Benefits and Industrial Challenges 1
Parmjit Singh Panesar, Anil Kumar Anal and Rupinder Kaur

1.1 Introduction 1

1.2 Probiotics 2

1.2.1 Mechanism of Action 3

1.3 Prebiotics 4

1.3.1 Mechanism of Action 5

1.4 Applications of Synbiotics 5

1.4.1 Diarrhea 5

1.4.2 Lactose Intolerance 5

1.4.3 Modulation of the Immune System 6

1.4.4 Prevention of Colon Cancer 6

1.4.5 Cardiovascular Disease 7

1.4.6 Gut-brain Axis: Role of Probiotics 7

1.5 Current Outlook and Industrial Challenges 8

1.6 Conclusion 8

References 9

2 Isolation, Identification and Characterization of Beneficial Microorganisms from Traditional Fermented Foods 14
Phu-Ha Ho, Tuan-Anh Pham, Quoc-Phong Truong, Lan-Huong Nguyen, Tien-Thanh Nguyen, Hang-Thuy Dam, Chinh-Nghia Nguyen, Ha-Anh Nguyen, Quyet-Tien Phi, Hoang Anh Nguyen and Son Chu-Ky

2.1 Introduction 14

2.2 Fermented Food as a Source of Probiotic Microorganisms 14

2.2.1 Fermented Food and Health Benefits 14

2.2.2 Occurrence of Probiotics in Fermented Foods 16

2.2.3 Probiotic Viability in Fermented Food 20

2.3 Probiotic Isolation 22

2.3.1 Traditional Culture-dependent Approach 22

2.3.2 Culturomics Approach 26

2.4 Identification of Probiotic Microorganisms 28

2.4.1 Phenotypic Identification 28

2.4.2 Biochemical Identification 28

2.4.3 Molecular Identification 28

2.4.3.1 Specific Gene Analysis 28

2.4.3.2 Metagenomic Analysis 30

2.4.3.3 Proteomics 30

2.4.3.4 Metabolomics 30

2.5 Characterization of Probiotic Microorganisms 30

2.6 Conclusion 47

Acknowledgements 47

References 47

3 Lactic Acid Bacteria as Potential Probiotics 57
Muhammad Bilal Sadiq

3.1 Introduction 57

3.2 Isolation and Identification of Lactic Acid Bacteria 58

3.3 Characterization of Lactic Acid Bacteria 58

3.4 Criteria for Selection of Lactic Acid Bacteria as Potential Probiotic Candidates 59

3.4.1 Evaluation of Gastric Survival 59

3.4.2 Bile Salt Hydrolysis Activity 60

3.4.3 Adhesion to Epithelium 61

3.4.4 Hydrophobicity 61

3.4.5 Aggregation Ability 61

3.4.6 Antimicrobial Potential 61

3.4.7 Amylolytic Property 63

3.4.8 Safety Evaluation 63

3.5 Lactic Acid Bacteria as Sources of Probiotics 63

3.5.1 Fruits and Vegetables 63

3.5.2 Animal Sources 64

3.5.3 Dairy Products 64

3.6 Health Benefits and Probiotic Mechanisms of Lactic Acid Bacteria 65

3.6.1 Host Immunity 65

3.6.2 Beneficial Metabolites 65

3.6.3 Lactose Intolerance 66

3.6.4 Gastric Ulcer 66

3.6.5 Obesity and Diabetes Management 66

3.6.6 Role of Lactic Acid Bacteria Probiotics in Cancer 67

3.7 Industrial Applications of Probiotic Lactic Acid Bacteria 67

3.8 Challenges for Lactic Acid Bacteria as Probiotics 67

3.9 Conclusion and Future Perspectives 68

References 68

4 Non-Lactic Acid Bacteria as Probiotics and their Functional Roles 73
Cíntia Lacerda Ramos, Elizabethe Adriana Esteves, Nayara Martins Zille de Miranda, Lauane Gomes Moreno and Rosane Freitas Schwan

4.1 Spore-forming Bacteria 73

4.1.1 Types, Structure and Formation of Spores 74

4.1.1.1 Structure 75

4.1.1.2 Spore Formation 76

4.1.2 Sources and Probiotic Potential of Spore-forming Strains 77

4.1.3 Spore Formers as Gut Microbiota 80

4.1.4 Interaction with the Intestinal Cells 82

4.2 Propionibacteria 84

4.2.1 Phenotypic and Genotypic Characterization 84

4.2.2 Probiotic Properties and Potential Mechanisms of Action 86

4.2.2.1 Immunomodulation 86

4.2.2.2 Microbiota Modulation 89

4.2.2.3 Cancer Modulation 89

4.3 Conclusion and Future Trends 90

References 91

5 Yeasts as Probiotics and their Functional Roles 103
Giorgia Perpetuini, Yves Waché and Rosanna Tofalo

5.1 Yeasts: General Considerations and Taxonomy 103

5.2 Saccharomyces boulardii 105

5.3 Mechanism of Action of Yeast Probiotics 107

5.4 Health Benefits of Yeast Probiotics 109

5.4.1 Probiotic Effects 110

5.4.2 Nutritional Effects 111

5.5 Other Yeast Strains with Probiotic Potential 112

5.6 Encapsulation 113

5.7 Conclusion and Future Challenges 114

References 115

6 Determination and Safety Aspects of Probiotic Cultures 122
Falguni Patra and Raj Kumar Duary

6.1 Introduction 122

6.2 Assessments of Probiotics in the Gut 123

6.2.1 Direct Method 123

6.2.2 Indirect Method 125

6.3 Dosage for Probiotic Effect 126

6.4 Pathogenicity and Inefficiency of Probiotic Culture 126

6.4.1 Pathogenicity of Probiotics 126

6.4.2 Inefficiency of Probiotics 129

6.5 Safety Assessment of Probiotic Cultures 130

6.5.1 Current Proposal on Probiotic Safety 131

6.5.2 Identification of Individual Strains 134

6.5.3 In vitro studies 135

6.5.4 Animal Studies 138

6.5.5 Human Clinical Studies 140

6.5.6 Antibiotic Resistance - the Probability of Transfer of Resistance 145

6.5.7 Post-marketing Surveillance - Genotoxic Studies, Toxin and Virulence Factors 148

6.6 Conclusion 150

References 150

7 Probiotics in Biodegradation of Microbial Toxins: Principles and Mechanisms 161
Ali Akbar, Muhammad Iftikhar Khan and Ghulam Ishaq Khan

7.1 Microbial Toxins 161

7.1.1 Health Benefits 162

7.1.2 Mycotoxins and Probiotics 162

7.2 Dual Interaction between Probiotics and Microbial Toxins 164

7.2.1 Clinical Trials 165

7.2.2 Types of Microbial Adsorbents for Mycotoxin Adsorption 165

7.2.2.1 Lactic Acid Bacteria 165

7.3 Principles and Mechanisms Involved 166

7.3.1 Control of Mycotoxins by Yeast 167

7.4 Conclusion and Future Prospects 168

Acknowledgement 168

References 168

8 Potential of Probiotics as Alternative Sources for Antibiotics in Food Production Systems 172
Sarina Pradhan Thapa, Sushil Koirala and Anil Kumar Anal

8.1 Introduction 172

8.2 Use of Antibiotics in the Food System 173

8.3 Classification and Mechanism of Use of Antibiotics 174

8.4 Mechanism of Probiotic Action 175

8.5 Probiotic Approach to Antibiotic Resistance 178

8.6 Probiotics as Alternative Sources for Antibiotics: What Is Known So Far 178

8.7 Conclusion and Future Prospects 180

References 180

9 Probiotic Cereal-based Food and Beverages, their Production and Health Benefits 186
Sujitta Raungrusmee, Simmi Ranjan Kumar and Anil Kumar Anal

9.1 Introduction 186

9.2 Probiotics in Cereal-based Food and Beverages 187

9.3 General Information about Probiotics 188

9.4 Mechanism/Pathway for Probiotics in Cereal-based Food and Beverages 189

9.5 Types of Probiotic in Cereal-based Food and Beverages 191

9.6 Traditional and Commercial Probiotic Cereal-based Foods and Beverages 191

9.6.1 Borde 191

9.6.2 Boza 197

9.6.3 Burukutu 197

9.6.4 Bushera 197

9.6.5 Chicha de jora 197

9.6.6 Gowe 198

9.6.7 Kenky 198

9.6.8 Koko 198

9.6.9 Koozh 198

9.6.10 Kunun-zaki 198

9.6.11 Kvass 198

9.6.12 Kwete 199

9.6.13 Mageu 199

9.6.14 Majewu 199

9.6.15 Obiolo 199

9.6.16 Ogi 199

9.6.17 Pito 200

9.6.18 Pozol 200

9.6.19 Sobia 200

9.6.20 Togwa 201

9.6.21 Uji 201

9.6.22 Yosa 201

9.6.23 Commercially Available Cereal-based Functional Foods 201

9.7 Health Benefits 203

9.8 Conclusion 209

References 209

10 Microencapsulation of Probiotics and its Potential Industrial Applications 213
Suwan Panjanapongchai, Chaichawin Chavapradit and Anil Kumar Anal

10.1 Introduction 213

10.2 Why We Need Microencapsulation 214

10.3 Encapsulation Techniques 215

10.3.1 Emulsion Technique 215

10.3.2 Extrusion Technique 216

10.3.3 Coacervation Technique 217

10.3.4 Spray Drying 218

10.3.5 Ultrasonic Vacuum Spray Dryer 219

10.3.6 Freeze Drying 219

10.3.7 Spray Freeze Drying 219

10.3.8 Spray Chilling 220

10.3.9 Fluid Bed Coating 220

10.3.10 Electrospraying and Electrospinning 221

10.3.11 Impinging Aerosol Technology 222

10.3.12 Hybridization method 222

10.4 Application of Probiotics in Food Matrices 223

10.4.1 Dairy Products 223

10.4.1.1 Yoghurt 223

10.4.1.2 Cheese 225

10.4.1.3 Desserts 225

10.4.2 Non-dairy Products 226

10.4.2.1 Beverages 226

10.4.2.2 Meat Products 226

10.4.2.3 Bakery Products 227

References 227

11 Prebiotics and their Role in Functional Food Product Development 233
Divyani Panwar, Parmjit Singh Panesar and Anuradha Saini

11.1 Introduction 233

11.2 Sources of Prebiotics: Classification and Characteristics 235

11.2.1 Characteristics of Prebiotics 235

11.2.2 Classification of Prebiotics and their Sources 235

11.2.2.1 Galactooligosaccharides 238

11.2.2.2 Fructooligosaccharides 238

11.2.2.3 Xylooligosaccharides 239

11.2.2.4 Lactulose 239

11.2.2.5 Lactosucrose 240

11.2.2.6 Inulin 240

11.2.2.7 Isomaltosoligosaccharides 240

11.3 New and Tailored Prebiotics 241

11.3.1 Human Milk Oligosaccharides 241

11.3.2 Resistant Starch 242

11.3.3 Polyphenols 242

11.3.4 Soybean Oligosaccharides 243

11.3.5 Lactitol 243

11.3.6 Microbial Exopolysaccharides 243

11.3.7 Seaweed Polsaccharides 244

11.4 Production Methods of Prebiotics 244

11.4.1 Galactooligosaccharides 245

11.4.2 Fructooligosaccharides 247

11.4.3 Xylooligosaccharides 247

11.4.4 Lactulose 248

11.5 Mechanism of Action 248

11.6 Health Benefits of Prebiotics 249

11.6.1 Acute Gastroenteritis 249

11.6.2 Reduction in Constipation 250

11.6.3 Reduced Risk of Colon Cancer 254

11.6.4 Obesity 254

11.6.5 Diabetes 255

11.6.6 Mineral Absorption 255

11.6.7 Lipid Metabolism 255

11.7 Safety Aspects of Prebiotics 256

11.8 Global Status of Prebiotics 256

11.9 Conclusion and Future Prospects 258

References 259

12 Galactooligosaccharides as Potential Prebiotics 272
Rupinder Kaur and Parmjit Singh Panesar

12.1 Introduction 272

12.2 Galactooligosaccharides 273

12.3 Technologies for Synthesis of Galactooligosaccharides 274

12.3.1 Chemical Technique for Production of GOS 274

12.3.2 Enzymatic Production of GOS 275

12.3.2.1 Glycosyltransferases 276

12.3.2.2 Glycosidases 276

12.4 Biotechnological Strategies for Biotransformation of GOS 277

12.4.1 Factors Affecting GOS Production 279

12.4.2 Production of GOS using Whole Cells 281

12.4.3 Production of GOS using Free Enzyme 286

12.4.4 Production of GOS using Immobilized Enzyme 286

12.4.5 Improvement in GOS Production 287

12.5 Global Status of GOS 288

12.6 Applications of GOS as Prebiotics 290

12.6.1 Stimulation of Health-promoting Bacteria 292

12.6.2 Modulation of Immune System 292

12.6.3 Enhancement of Mineral Absorption 293

12.6.4 Reduction in the Risk of Colon Cancer 294

12.6.5 Inflammatory Bowel Disease 295

12.7 Conclusion and Future Prospects 295

References 296

13 Fructooligosaccharides as Prebiotics, their Metabolism, and Health Benefits 307
Orlando de la Rosa, Adriana C. Flores-Gallegos, Juan A. Ascacio-Valdés, Leonardo Sepúlveda, Julio C. Montáñez and Cristóbal N. Aguilar

13.1 Introduction 307

13.2 Chemical Structure and Sources 307

13.3 Prebiotic Concept 308

13.4 Health-promoting Properties 310

13.4.1 Prebiotic Activity 310

13.4.2 Influence of Gut Microbiome 310

13.4.3 Prevention against Colon Cancer and Immunomodulation 313

13.4.4 Impact on Obesity 315

13.4.5 Effects on Serum Lipid and Cholesterol Concentrations 315

13.4.6 Improving Mineral Adsorption 316

13.5 FOS Production 316

13.5.1 FOS Formation Kinetics 318

13.5.2 Biotechnological Production of FOS 320

13.5.3 Enzymatic Synthesis 321

13.5.4 Whole Cell/One-step Fermentation 322

13.5.5 Agro-industrial Residues and Bioresources Employed for FOS Production 323

13.6 FOS Purification 323

13.6.1 Nanofiltration 323

13.6.2 Activated Charcoal 323

13.6.3 Microbial Treatments 324

13.7 New Developments in Food 325

13.8 Conclusion 325

Acknowledgements 326

References 326

14 Lactulose: Production and Potential Applications 338
Shweta Kumari, Parmjit Singh Panesar, Divyani Panwar and Gisha Singla

14.1 Introduction 338

14.2 Structure and Properties 338

14.3 Lactulose Production 340

14.3.1 Chemical Methods 341

14.3.2 Biotechnological Methods 345

14.3.2.1 Enzymatic Methods 345

14.3.2.2 Whole Cell Biocatalysts for Lactulose Production 348

14.3.3 Electro-activation Method 349

14.4 Techniques for the Analysis of Lactulose 349

14.5 Applications of Lactulose 350

14.5.1 Food Sectors 351

14.5.1.1 Lactulose as a Bifidus Factor 351

14.5.1.2 Lactulose as a Functional Additive 351

14.5.2 Health Sectors 351

14.5.2.1 Salmonella Carriers 351

14.5.2.2 Constipation and Hepatic Encephalopathy 352

14.5.2.3 Anti-endotoxin Effects 352

14.5.2.4 Colon Carcinogenesis 352

14.5.2.5 Inflammatory Bowel Disease 352

14.5.2.6 Tumor Prevention and Immunology 352

14.5.2.7 Blood Glucose and Insulin 353

14.5.2.8 Diagnostic Applications 353

14.6 Future Developments 353

14.7 Conclusion 353

References 354

15 Isomaltooligosaccharides as Prebiotics and their Health Benefits 361
Waraporn Sorndech

15.1 Isomaltooligosaccharide Structure, Properties and Market Trends 361

15.1.1 IMO: Global Patent Trend 364

15.2 Production 365

15.2.1 Enzymatic Production 365

15.2.1.1 Enzymatic Technologies for Formation of Various IMO Structures 366

15.2.1.2 Production Strategies 368

15.3 Technological Developments 368

15.3.1 Microbial Fermentation and Enzyme Genetic Engineering 368

15.3.2 Enzyme Immobilization 369

15.3.3 Enzyme Cocktails 369

15.3.4 Glucose, Fructose and Linear Oligosaccharide Elimination 369

15.4 Health Benefits of IMO 370

15.5 Conclusion 372

References 372

16 Starch and its Derivatives as Potential Source of Prebiotics 378
Yudi Pranoto

16.1 Introduction 378

16.2 Starch Digestion 379

16.3 Starch as a Probiotic Food Source 381

16.4 Resistant Starch as a Novel Prebiotic 382

16.5 Health Benefits 389

16.5.1 Hypoglycemic Effects 391

16.5.2 Hypocholesterolemic Effects 391

16.5.3 Prevention of Colon Cancer 392

16.5.4 Prebiotic Effect 393

16.5.5 Preventing Obesity 393

16.5.6 Reduction of Gallstone Formation 394

16.5.7 Mineral Absorption 395

16.6 Future Applications 395

16.6.1 Cheese 397

16.6.2 Pasta Products 398

16.6.3 Battered Fried Products 398

16.6.4 Bakery Products 398

16.6.5 Baked Goods 399

16.6.6 Microencapsulation of Probiotics 399

16.7 Production of RS-rich Ingredients 401

16.8 Conclusion 403

References 404

17 Gut Microbiome as Potential Source for Prevention of Metabolic-Related Diseases 407
Nuntarat Boonlao, Krisha Pant and Anil Kumar Anal

17.1 Introduction 407

17.2 Gut Microbiome and Host Interaction 408

17.2.1 Microbial Composition and Colonization 408

17.2.2 Non-bacterial Growth in the Intestine 409

17.2.3 Next Generation Probiotics 409

17.2.4 Host Cell and Microbes - Symbiotic Relationship 410

17.3 Gut Microbes and Diet Interaction 410

17.3.1 Carbohydrate 413

17.3.2 Proteins 413

17.3.3 Complex Carbohydrate/Fibers 413

17.3.4 Fat 414

17.3.5 Probiotics 414

17.3.6 Phenolic Compounds 414

17.4 Gut Microbiome and Metabolism Regulation 415

17.4.1 Gut Microbiome and Brain 415

17.4.1.1 Neural Pathways 415

17.4.1.2 Metabolites 416

17.4.2 Gut Microbiome and Immune System 416

17.4.3 Gut and Regulation of Metabolism 416

17.4.4 Gut Microbiome and COVID-19 417

17.5 Role of Gut Microbiome on Metabolic Diseases 417

17.5.1 Gut Barrier and Inflammation 417

17.5.2 Microbial Metabolites 419

17.5.2.1 Bile Acid 419

17.5.2.2 Trimethylamine-N-oxide (TMAO) 420

17.6 Gut Microbiome and Metabolic Diseases 421

17.6.1 Obesity 421

17.6.2 Type 2 Diabetes Mellitus 422

17.7 Modulation of Gut Microbiome as Target for Prevention of Metabolic Diseases 423

17.7.1 Role of Dietary Intervention 423

17.7.2 Role of Probiotics and Prebiotics 424

17.8 Possible Mechanisms of Gut Microbiome in Prevention of Metabolic Diseases 425

17.8.1 Roles of Short Chain Fatty Acids 425

17.8.2 Role of Bile Salt Hydrolase 426

17.8.3 Role on Intestinal Barrier Function 427

17.9 Conclusion and Future Perspective 427

References 427

18 Overall Safety Considerations and Regulatory Oversight for Probiotics-based Foods and Beverages 441
Sushil Koirala, Sarina Pradhan Thapa and Anil Kumar Anal

18.1 Introduction 441

18.2 Safety Considerations 443

18.2.1 Non-pathogenicity 443

18.2.2 Virulome Factors 445

18.2.3 Absence of Antibiotic Resistance 445

18.3 Regulatory Framework and Labeling Claims Associated with Probiotic-based Foods and Beverages 446

18.3.1 Key Market Insights 448

18.3.2 Regional and Country Analysis 449

18.3.2.1 USA 449

18.3.2.2 Europe 450

18.3.2.3 Japan 452

18.3.2.4 China 453

18.3.2.5 Brazil 453

18.3.2.6 Mexico 454

18.3.2.7 India 454

18.3.2.8 Thailand 454

18.3.2.9 Malaysia 455

18.3.2.10 Singapore 455

18.4 Conclusion and Future Expectations 456

References 456

Index 462

Authors

Parmjit Singh Panesar Sant Longowal Institute of Engineering and Technology Sangrur, India. Anil Kumar Anal Asian Institute of Technology (AIT), Thailand.